141 related articles for article (PubMed ID: 614040)
1. [Treatment of thyroid neoplasms and proposed therapeutic plan].
Paolucci R; La Torre P; Salcuni PF; Foggi E; Vitali M
Ateneo Parmense Acta Biomed; 1977; 48(5):483-97. PubMed ID: 614040
[TBL] [Abstract][Full Text] [Related]
2. Treatment of thyroid cancer in 293 patients.
Staunton MD; Greening WP
Br J Surg; 1976 Apr; 63(4):253-8. PubMed ID: 1276656
[TBL] [Abstract][Full Text] [Related]
3. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic approach to differentiated carcinoma of the thyroid gland].
Busnardo B
Minerva Endocrinol; 1987; 12(1):69-73. PubMed ID: 3587203
[No Abstract] [Full Text] [Related]
5. Papillary and follicular thyroid cancer: selective therapy.
Mazzaferri EL
Compr Ther; 1981 May; 7(5):6-14. PubMed ID: 7016424
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated thyroid neoplasia: a curable cancer.
Ferguson CM
J Med Assoc Ga; 1988 Nov; 77(11):846-9. PubMed ID: 3057101
[No Abstract] [Full Text] [Related]
7. [On the treatment of carcinoma of the thyroid (author's transl)].
Biersack HJ; Vogt M; Helpap B; Janson R; Rau W; Winkler C
Dtsch Med Wochenschr; 1981 Mar; 106(13):390-5. PubMed ID: 7215162
[TBL] [Abstract][Full Text] [Related]
8. [Current state of the treatment of thyroid cancer].
Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
[TBL] [Abstract][Full Text] [Related]
9. [Differentiated cancer of the thyroid. Prognostic factors and therapeutic attitude].
Almou M; Alaoui M; Mokhtari M; el Alaoui M; Mansouri A
Acta Chir Belg; 1989; 89(5):271-5. PubMed ID: 2816209
[TBL] [Abstract][Full Text] [Related]
10. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
11. [Therapy and survival in thyroid tumors].
Rodari A
Minerva Med; 1986 Nov; 77(44):2127-30. PubMed ID: 3785730
[No Abstract] [Full Text] [Related]
12. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
13. Proceedings: Management of cancer of the thyroid: a summary.
Strong EW
Proc Natl Cancer Conf; 1972; 7():179-85. PubMed ID: 4587645
[No Abstract] [Full Text] [Related]
14. Carcinoma of thyroid--clinical presentation and outcome.
Sothy K; Mafauzy M; Mohamad WB; Mustaffa BE
Med J Malaysia; 1991 Sep; 46(3):212-7. PubMed ID: 1839914
[TBL] [Abstract][Full Text] [Related]
15. The coexistence of anaplastic and papillary carcinomas of the thyroid: a case presentation and literature review.
Fortson JK; Durden FL; Patel V; Darkeh A
Am Surg; 2004 Dec; 70(12):1116-9. PubMed ID: 15663057
[TBL] [Abstract][Full Text] [Related]
16. Difficult decisions in the management of thyroid carcinoma.
Friedman M; Loré JM; Paloyan E; Skolnik EM
Otolaryngol Clin North Am; 1986 Aug; 19(3):463-73. PubMed ID: 3748576
[TBL] [Abstract][Full Text] [Related]
17. A review of the treatment of 222 patients with malignant tumours of the thyroid gland.
Taylor S; Davis PW
Monogr Neoplast Dis Var Sites; 1970; 6():243-58. PubMed ID: 5527676
[No Abstract] [Full Text] [Related]
18. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
19. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
Börner W; Reiners C
Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
[No Abstract] [Full Text] [Related]
20. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
